Dr. Mikkael Skeres, MD, shares his thoughts and experience with Imetelstat, a first in class telomerase inhibitor for use in patients with lower-risk Myelodysplastic syndromes.
EP. 1: Anemia in Lower-Risk MDS: Introduction and Case Presentation
Mikkael Sekeres, MD details a clinical presentation of a 74-year-old man diagnosed 9 months ago with LR-MDS with a hemoglobin of 7.8 g/dL.
Watch
EP. 2: Lower-Risk MDS: Frontline Therapy Initiation and Determination of Treatment Failure
Dr Sekeres discusses when to start therapy for a patient who has lower-risk MDS with amnesia.
EP. 3: Second-Line Therapy for ESA-Refractory, Transfusion Dependent Lower-Risk MDS: Imetelstat
Dr Sekeres discusses how he approaches second-line therapy selection in ESA-refractory, transfusion-dependent lower-risk MDS (LR-MDS) patients, specifically with imetelstat.
EP. 4: Patient Treatment Goals for Lower-Risk MDS
Dr Sekeres discusses treatment goals for a patient with lower-risk MDS.
EP. 5: Second-Line Therapy for ESA-Refractory, Transfusion Dependent Lower-Risk MDS: Luspatercept
Dr Sekeres discusses how he approaches second-line therapy selection in ESA-refractory, transfusion-dependent lower-risk MDS (LR-MDS) patients, specifically with luspatercept.
EP. 6: Optimizing Anemia Management in Lower-Risk MDS: Key Takeaways
Dr Sekeres discusses key takeaways for optimizing anemia management in lower-risk MDS, as well as where he sees the most significant unmet needs.
EP. 7: Second-Line Therapy for ESA-Refractory, Transfusion Dependent Lower-Risk MDS: Lenalidomide
Dr Sekeres discusses how he approaches second-line therapy selection in ESA-refractory, transfusion-dependent lower-risk MDS (LR-MDS) patients, specifically with lenalidomide.
EP. 8: Second-line Treatment for RS-negative Lower-Risk MDS: Choosing Between EMA and Telomerase Inhibitor Options
Dr Sekeres shares his thoughts about the choice between an EMA and a telomerase inhibitor in the RS-negative patient.
EP. 9: Adverse Event Profile and Management of Imetelstat
Dr Sekeres discusses the adverse event profile and AE management of imetelstat.